Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)-Reference-Cited by-同舟云学术

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

Published:2022-02 Issue:2 Volume:54 Page:170-182
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Marchesini Giulio,Bugianesi Elisabetta,Burra Patrizia,Marra Fabio,Miele Luca,Alisi Anna,Vajro Piero,Masarone Mario,Petta Salvatore,Persico Marcello,Svegliati-Baroni Gianluca,Valenti Luca,Federici Massimo,Purrello Francesco,Sasso Ferdinando Carlo,Targher Giovanni,Busetto Luca,Petroni Maria Letizia,Santini Ferruccio,Cammà Calogero,Colli Agostino

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference284 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. The natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the simtuzumab trials;Sanyal;Hepatology,2019

3. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver;Dongiovanni;J Intern Med,2018

4. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease;J Hepatol,2016

5. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement;Eslam;J Hepatol,2020

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breakthrough in the Treatment of Metabolic Associated Steatotic Liver Disease: Is it all over?;Digestive and Liver Disease;2024-09

2. Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease;World Journal of Gastroenterology;2024-08-14

3. Analysis of Metabolic Changes in Endogenous Metabolites and Diagnostic Biomarkers for Various Diseases Using Liquid Chromatography and Mass Spectrometry;Biological and Pharmaceutical Bulletin;2024-06-01

4. Evaluating cardiovascular risk in metabolic steatosis with precision medicine non-invasive approaches: insights from a cohort study;Internal and Emergency Medicine;2024-05-16

5. Use of non‐invasive diagnostic tools for metabolic dysfunction‐associated steatohepatitis: A qualitative exploration of challenges and barriers;Liver International;2024-04-18